Simr Biotechnology Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $9.5M

  • Investors
  • 9

Simr Biotechnology General Information

Description

Manufacturer of pharmaceutical compounds designed for the treatment of pain, inflammation, and central nervous system disorders. The company offers compound screening, chemical manufacturing, control research, preclinical evaluation, and clinical development, thereby enabling the biopharmaceutical industry to advance drug candidates through various stages of development, including clinical trials for conditions such as neuropathic pain, diabetic macular edema, and depression.

Contact Information

Website
www.simrbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 26, Lane 100, Banxia Road
  • Pudong New Area
  • Shanghai, 201318
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Number 26, Lane 100, Banxia Road
  • Pudong New Area
  • Shanghai, 201318
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Simr Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 14-Nov-2024 $9.5M Completed Generating Revenue
10. Secondary Transaction - Private 17-Oct-2024 Completed Generating Revenue
9. Secondary Transaction - Private 24-Sep-2024 Completed Generating Revenue
8. Later Stage VC (Series C1) 08-Nov-2022 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series B1) 14-Jul-2021 Completed Clinical Trials - Phase 1
6. Early Stage VC (Series B) 12-Nov-2018 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 01-Nov-2018 Completed Pre-Clinical Trials
4. Early Stage VC 31-Aug-2017 Completed Pre-Clinical Trials
3. Early Stage VC 01-Nov-2016 Completed Pre-Clinical Trials
2. Early Stage VC 01-Jun-2015 Completed Pre-Clinical Trials
To view Simr Biotechnology’s complete valuation and funding history, request access »

Simr Biotechnology Patents

  • 70

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 30

    Pending

  • Expiring in next 12 mo

Simr Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026026970-A1 Fused ring compound, and intermediate thereof and use thereof Pending 02-Aug-2024
WO-2026026971-A1 Imidazole fused ring compound, and preparation method therefor and use thereof Pending 02-Aug-2024
WO-2025002454-A1 Use of compound in preparation of drug for preventing, relieving, assisting in treating, or treating lung injury Inactive 29-Jun-2023
AU-2024262043-A1 Imidazopyridine or imidazopyrazine compound, preparation method therefor, and pharmaceutical composition and use thereof Pending 24-Apr-2023
EP-4703359-A1 Imidazopyridine or imidazopyrazine compound, preparation method therefor, and pharmaceutical composition and use thereof Pending 24-Apr-2023 C07D471/04
To view Simr Biotechnology’s complete patent history, request access »

Simr Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Simr Biotechnology Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yangshengtang Limited Group Corporation Minority
Guanzi Private Equity Fund Management Growth/Expansion Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Zhangjiang Hi-Tech Investment Corporate Venture Capital Minority
Zhangjiang Hi-Tech Park Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Simr Biotechnology FAQs

  • When was Simr Biotechnology founded?

    Simr Biotechnology was founded in 2014.

  • Where is Simr Biotechnology headquartered?

    Simr Biotechnology is headquartered in Shanghai, China.

  • What is the size of Simr Biotechnology?

    Simr Biotechnology has 9 total employees.

  • What industry is Simr Biotechnology in?

    Simr Biotechnology’s primary industry is Biotechnology.

  • Is Simr Biotechnology a private or public company?

    Simr Biotechnology is a Private company.

  • What is the current valuation of Simr Biotechnology?

    The current valuation of Simr Biotechnology is .

  • What is Simr Biotechnology’s current revenue?

    The current revenue for Simr Biotechnology is .

  • How much funding has Simr Biotechnology raised over time?

    Simr Biotechnology has raised $80.6M.

  • Who are Simr Biotechnology’s investors?

    Yangshengtang Limited Group, Guanzi Private Equity Fund Management, Shenzhen Yifeng Investment Management Enterprise, Zhangjiang Hi-Tech Investment, and Zhangjiang Hi-Tech Park are 5 of 9 investors who have invested in Simr Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process